Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/13/2025

Valvular Heart Disease Management

Indications for Surgery

  • The European Society of Cardiology recommends surgical aortic valve replacement (AVR) for all symptomatic patients with severe aortic regurgitation, regardless of left ventricular function, and for asymptomatic patients with left ventricular dysfunction (LVEF <50-55%) or significant left ventricular dilation 1
  • Emergency surgical intervention is required for patients with severe aortic regurgitation, with a Class I recommendation 1
  • AVR is indicated regardless of LV systolic function, with a Class I recommendation 1
  • AVR is indicated when LVEF <50-55% if no other cause for LV dysfunction is identified, with a Class I recommendation 1
  • AVR is reasonable when LVESD >50 mm, with a Class I recommendation, and when LVESD >45 mm, with a Class IIa recommendation 1
  • AVR may be considered with progressive decline in LVEF on serial studies or with progressive LV dilation (LVEDD >65 mm) 1

Concomitant Procedures

  • AVR is indicated for severe AR when undergoing CABG or surgery of the ascending aorta/other heart valves, with a Class I recommendation 1
  • AVR is reasonable for moderate AR when undergoing other cardiac surgery, with a Class IIa recommendation 1
  • If aortic dimension ≥45 mm, replacement of aortic sinuses/ascending aorta is reasonable when performed at a comprehensive valve center 1

Valve Replacement Options

  • Mechanical or bioprosthetic valve replacement is the standard approach, as recommended by the European Society of Cardiology 1
  • Valve repair may be considered in selected patients with favorable anatomy at experienced centers, with a strength of evidence classified as reasonable 1
  • Transcatheter aortic valve implantation (TAVI) may be considered in experienced centers for patients ineligible for surgical AVR, with a strength of evidence classified as reasonable 1

Diagnostic Criteria

  • The following criteria are used to diagnose severe aortic regurgitation:
Criteria Threshold
Vena contracta >0.6 cm
Regurgitant volume ≥60 mL/beat
Effective regurgitant orifice area (EROA) ≥0.3 cm²
Holodiastolic flow reversal in the descending aorta present
Evidence of LV dilation present
Doppler jet width ≥65% of LVOT
Regurgitant fraction ≥50%
Pressure half-time of regurgitant jet <200 m/s

Medical Management

  • For patients with prohibitive surgical risk, guideline-directed medical therapy (GDMT) for reduced LVEF including ACE inhibitors, ARBs, and/or sacubitril/valsartan is recommended, with a strength of evidence classified as Class I recommendation 1
  • Medical therapy has a limited role and should not delay surgical intervention, but may be used for symptomatic improvement in patients not suitable for surgery, or for optimal guideline-directed medical therapy for heart failure 1, 2, 3

Special Considerations

  • Pregnancy: close monitoring, especially in the third trimester, and avoidance of ACE inhibitors and angiotensin receptor antagonists for pregnant patients with regurgitant valve lesions, as recommended by the American College of Cardiology 4
  • Post-myocardial infarction: urgent surgical intervention for papillary muscle rupture presenting as sudden hemodynamic deterioration, which can occur 2-7 days post-myocardial infarction, with a strength of evidence classified as Class I recommendation 5, 6
  • Non-cardiac surgery: can be performed safely in asymptomatic patients with preserved LV function, but patients with severe aortic regurgitation undergoing other cardiac procedures should have the aortic valve addressed during the same operation, with a strength of evidence classified as Class I recommendation 1, 7

Contraindications

  • Intra-aortic balloon counterpulsation is contraindicated in acute AR, as recommended by the European Society of Cardiology 1
  • The American College of Cardiology and European Heart Journal recommend understanding the specific type of regurgitation for appropriate management, with treatment directed at the underlying cause and severity of symptoms, with a strength of evidence classified as Class I recommendation 3, 5